Back to Search
SUBHASH BHANOT, MD
MD
Urology Physician
NPI: 1356370142Individual
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
12647(WV)
Research & Publications (20)
Inhibition of protein tyrosine phosphatase-1B with antisense oligonucleotides improves insulin sensitivity and increases adiponectin concentrations in monkeys.
PMID 19164474·Endocrinology·2009
7-preclinical
The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance.
PMID 19254570·Cell Metab·2009
7-preclinical
Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids.
PMID 19472314·Hepatology·2009
7-preclinical
SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats.
PMID 19549853·Proc Natl Acad Sci U S A·2009
7-preclinical
Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice.
PMID 18523126·Am J Physiol Endocrinol Metab·2008
7-preclinical
Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma.
PMID 18584035·PLoS Genet·2008
7-preclinical
Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase.
PMID 18832746·Circ Res·2008
7-preclinical
Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression.
PMID 18198353·Am J Physiol Endocrinol Metab·2008
7-preclinical
Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis.
PMID 18000880·Hepatology·2008
7-preclinical
Reduction of low molecular weight protein-tyrosine phosphatase expression improves hyperglycemia and insulin sensitivity in obese mice.
PMID 17353188·J Biol Chem·2007
7-preclinical
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
PMID 17476695·Hepatology·2007
7-preclinical
Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease.
PMID 17478431·J Biol Chem·2007
7-preclinical
Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease.
PMID 17318260·J Clin Invest·2007
7-preclinical
Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins.
PMID 17273170·Nat Med·2007
4-observational
Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.
PMID 17526931·J Biol Chem·2007
7-preclinical
Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes.
PMID 17068142·Endocrinology·2007
7-preclinical
Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2.
PMID 16485039·J Clin Invest·2006
7-preclinical
Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.
PMID 16741579·J Clin Invest·2006
7-preclinical
Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action.
PMID 16804074·Diabetes·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 140 STOLLINGS AVE, SUITE 1
LOGAN, WV 25601 - Phone
- (304) 752-2555
Quick Facts
- NPI
- 1356370142
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile